The inspection for the assessment by European experts of the Russian drug for coronavirus “Sputnik V” will take place no earlier than January 2022. This was reported in the press service of the World Health Organization (WHO), reports RIA News…
WHO representatives met with members of the Russian Direct Investment Fund (RDIF) to discuss the need to share more information on the quality, safety and efficacy of the vaccine.
“The company has pledged to provide a detailed data filing roadmap so that WHO can expedite vaccine evaluation,” it said.
Earlier, the head of the RDIF, Kirill Dmitriev, explained the delay in the approval of the Russian vaccine against the Sputnik V coronavirus by the WHO. According to him, the obstacles are purely bureaucratic.
Currently “Sputnik V” is registered in 70 countries, the total population of which is about four billion people. The drug is manufactured by more than 20 companies in 14 countries around the world.
#announced #start #date #testing #Sputnik